These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11361289)

  • 1. Losartan use in mild to moderate hypertension--adverse effects in moderate to severe renal failure.
    Gupta S; Dash SC; Bhowmik D; Mohanty NK; Agarwal SK; Tiwari SC
    J Assoc Physicians India; 2001 May; 49():591. PubMed ID: 11361289
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics, safety, and antihypertensive efficacy of losartan in combination with hydrochlorothiazide in hypertensive patients with renal impairment.
    Dickson TZ; Zagrobelny J; Lin CC; Ritter MA; Snavely D; Ramjit D; Shahinfar S; Lo MW
    J Clin Pharmacol; 2003 Jun; 43(6):591-603. PubMed ID: 12817522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis].
    Khazine F; Simons O
    Nephrologie; 2001; 22(2):73. PubMed ID: 11385903
    [No Abstract]   [Full Text] [Related]  

  • 4. Aphtous ulcers of the mouth associated with losartan.
    Goffin E; Pochet JM; Lejuste P; De Plaen JF
    Clin Nephrol; 1998 Sep; 50(3):197. PubMed ID: 9776426
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
    Neki NS; Arora P
    J Indian Med Assoc; 2001 Nov; 99(11):640-1. PubMed ID: 12022207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
    James IG; Jones A; Davies P
    J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan and anaemia of end-stage renal disease.
    Lang SM; Schiffl H
    Lancet; 1998 Nov; 352(9141):1708. PubMed ID: 9853467
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AT1 receptor antagonist lorsartan and organ protection. Managing hypertension a different way].
    MMW Fortschr Med; 2006 Mar; 148(13):48-9. PubMed ID: 16642707
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of losartan and amilodipine on the platelet activation and renal function in patients with mild and moderate hypertension].
    Xie XM; Yu GL; Zhou P
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):130-2. PubMed ID: 12575338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction.
    Lee S
    Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875
    [No Abstract]   [Full Text] [Related]  

  • 14. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
    MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 16. Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
    Bass JK; Faix RG
    Am J Perinatol; 2006 Jul; 23(5):313-7. PubMed ID: 16799914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia due to ACE inhibitors and losartan in patients with renal failure.
    Prescrire Int; 1999 Dec; 8(44):179-80. PubMed ID: 11503817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Ersoy A; Kahvecioglu S; Ersoy C; Cift A; Dilek K
    Transplant Proc; 2005 Jun; 37(5):2148-50. PubMed ID: 15964363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
    Chowta KN; Chowta MN; Bhat P; Adhikari PM
    J Assoc Physicians India; 2002 Oct; 50():1236-9. PubMed ID: 12568205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.